The Impact of COVID-19 on Brand Prescribing and Claims
Truveris’ Life Sciences data science team conducted a deep-dive analysis to assess the impact of COVID-19 on prescribing and claim volume throughout an 18-month span.
Cell and Gene Therapy: Key Payer Considerations
Given the burgeoning pipeline of new cell and gene therapies, plan sponsors must understand the clinical, operational, & financial implications of these innovations.
Podcast - The Future of the PBM Landscape
Listen to Episode 26 of Employers Health’s HR Benecast, featuring a full-length conversation with Truveris CEO, Nanette Oddo.
Truveris Appoints Nanette Oddo President and Chief Executive Officer
Truveris announced today that Nanette Oddo, formerly Truveris’ Chief Strategy Officer, has been named President and Chief Executive Officer.
5 Misconceptions about Loss of Exclusivity that Impact Patient Retention
Loss of exclusivity can feel like a dramatic shift, forever changing a drug’s profitability. However, this doesn’t have to be your brand’s fate.
Industry Update: The Impact of Recent State Legislation on Copay Accumulator Programs
Recently, several states have passed legislation that prohibits the use of copay accumulator adjustment programs. How does this affect your organization?
The Drug Formulary Formula: What You Need to Know to Choose the Right PBM
Understanding the ins and outs of drug formularies is essential to making an informed decision on which PBM to select for your members.
Generic Drug Differences and MAC Pricing: What Plan Sponsors Need to Know
Generic versions of brand name medications are not all the same. Understanding their differences and the MAC pricing implications is critical for choosing the most cost-effective PBM.
Webinar - Payer Strategies for Anticipating and Managing Gene Therapy
Watch Truveris’ on-demand webinar outlining how Payers can best anticipate and manage new gene therapies.
What’s the Difference between a Specialty Drug and a Non-Specialty Drug?
Looking forward to the future of pharmacy, it’s critical to understand how a specialty drug is defined, how it differs from traditional, non-specialty drugs, and how specialty is impacting employers’ benefit plan designs.
Three Ways to Help Patients Navigate the Medicare Coverage Gap
Many Medicare patients end up not filling their high-cost prescriptions due to the Medicare coverage gap. What can manufacturers do to help Medicare patients stay adherent?
Webinar - Managing Specialty Costs: Strategies for Optimizing Your Self-Funded Pharmacy Benefits Program
Watch Truveris’ webinar to learn more about how you can better manage a self-funded specialty pharmacy program.
How Real-Time Benefits Checks Drive Patient Access
Using simple patient inputs to provide a customized view of specific coverage restrictions and out-of-pocket cost obligations, real-time benefits checks empower patients and providers to make informed decisions about care.
3 Ways to Build Better Copay Assistance Programs
Adopting these three approaches can help manufacturers to build a more effective affordability program.
What is a Pharmacy Benefit Manager (PBM) and how Does a PBM Impact the Pharmacy Benefits Ecosystem?
Pharmacy Benefits Managers, also referred to as PBMs, are, in essence, the intermediaries of almost every aspect of the pharmacy benefits marketplace.
The Benefits of Pharmacy Carve-Out Plans
Do you know how much your company spends on pharmacy benefits? If you don’t, you’re not alone.
7 Critical Terms to Help Save Money on Your PBM Contract
It’s not uncommon for employers to be confused with all the industry-speak and confusing jargon that surrounds the work of pharmacy-benefit managers (PBMs
Truveris Expands Leadership Team With Key Appointments
Under the leadership of CEO Jeff Eberle, Truveris has assembled a seasoned team of industry veterans to drive innovation and fuel the Company’s rapid growth trajectory.
Is Your Patient Abandonment Rate Really What You Think it is?
You likely already know what patient abandonment is: when a prescription is written by a doctor but never picked up at the pharmacy.
Is Your Copay Program Costing You More Than It’s Earning? Keep These Top 5 Metrics In Mind
While the goals of every copay program vary, the top 5 essential ROI metrics to track its success stay the same.
What Is A Single Source Generic and How Does It Impact Drug Pricing?
Before signing up for any new insurance plan, you should familiarize yourself with an often overlooked segment of insurance — your pharmacy benefits plan.